US Stock MarketDetailed Quotes

Vera Therapeutics (VERA)

Watchlist
  • 38.503
  • +1.803+4.91%
Trading May 13 14:28 ET
2.76BMarket Cap-6.95P/E (TTM)

Vera Therapeutics (VERA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
118.79%125.13M
88.71%315.47M
92.60%94.21M
68.53%83.93M
114.61%80.14M
83.83%57.19M
63.87%167.17M
80.98%48.91M
128.91%49.8M
69.97%37.34M
Selling and administrative expenses
145.80%39.12M
144.44%100.22M
124.17%34.9M
189.44%27.46M
173.23%21.95M
101.16%15.92M
72.35%41M
149.35%15.57M
67.73%9.49M
39.95%8.03M
-Selling and marketing expense
----
----
----
142,525.00%5.71M
190,450.00%3.81M
5,038.46%1.34M
----
----
--4K
--2K
-General and administrative expense
145.80%39.12M
144.44%100.22M
124.17%34.9M
189.44%27.46M
173.23%21.95M
101.16%15.92M
72.35%41M
149.35%15.57M
67.73%9.49M
39.95%8.03M
Research and development costs
108.37%86.01M
70.61%215.26M
77.86%59.31M
40.08%56.47M
98.54%58.2M
77.92%41.28M
61.29%126.17M
60.44%33.35M
150.40%40.31M
80.59%29.31M
Operating profit
-118.79%-125.13M
-88.71%-315.47M
-92.60%-94.21M
-68.53%-83.93M
-114.61%-80.14M
-83.83%-57.19M
-63.87%-167.17M
-80.98%-48.91M
-128.91%-49.8M
-69.97%-37.34M
Net non-operating interest income expense
-11.38%4.53M
29.49%16.95M
-24.60%3.61M
33.66%3.78M
39.29%4.45M
124.30%5.11M
212.14%13.09M
430.09%4.79M
132.51%2.83M
140.91%3.19M
Non-operating interest income
-7.98%6.36M
18.18%24.48M
-17.20%5.52M
20.48%5.74M
23.82%6.32M
64.98%6.91M
159.61%20.71M
239.95%6.66M
120.62%4.76M
127.96%5.1M
Non-operating interest expense
1.73%1.82M
-1.25%7.53M
1.76%1.9M
1.24%1.96M
-1.99%1.87M
-5.98%1.79M
101.43%7.63M
77.18%1.87M
105.30%1.94M
109.19%1.91M
Other net income (expense)
-211.92%-432K
-156.28%-1.09M
-172.06%-503K
-139.83%-137K
-288.71%-836K
-14.03%386K
5.74%1.94M
48.51%698K
-21.28%344K
-8.28%443K
Gain on sale of security
----
----
----
----
----
----
----
----
----
75.00%-7K
Other non- operating income (expenses)
-211.92%-432K
-156.28%-1.09M
-172.06%-503K
-139.83%-137K
-288.71%-836K
-14.03%386K
5.74%1.94M
48.51%698K
-21.28%344K
-13.31%443K
Income before tax
-134.13%-121.03M
-96.92%-299.61M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.42M
-131.95%-46.63M
-67.19%-33.71M
Income tax
0.00%1K
0.00%1K
Net income
-134.13%-121.03M
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
Net income continuous Operations
-134.13%-121.03M
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
Minority interest income
Net income attributable to the parent company
-134.13%-121.03M
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-134.13%-121.03M
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
Basic earnings per share
-108.64%-1.69
-69.45%-4.66
-93.06%-1.39
-48.24%-1.26
-93.55%-1.2
-44.64%-0.81
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
Diluted earnings per share
-108.64%-1.69
-69.45%-4.66
-93.06%-1.39
-48.24%-1.26
-93.55%-1.2
-44.64%-0.81
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 118.79%125.13M88.71%315.47M92.60%94.21M68.53%83.93M114.61%80.14M83.83%57.19M63.87%167.17M80.98%48.91M128.91%49.8M69.97%37.34M
Selling and administrative expenses 145.80%39.12M144.44%100.22M124.17%34.9M189.44%27.46M173.23%21.95M101.16%15.92M72.35%41M149.35%15.57M67.73%9.49M39.95%8.03M
-Selling and marketing expense ------------142,525.00%5.71M190,450.00%3.81M5,038.46%1.34M----------4K--2K
-General and administrative expense 145.80%39.12M144.44%100.22M124.17%34.9M189.44%27.46M173.23%21.95M101.16%15.92M72.35%41M149.35%15.57M67.73%9.49M39.95%8.03M
Research and development costs 108.37%86.01M70.61%215.26M77.86%59.31M40.08%56.47M98.54%58.2M77.92%41.28M61.29%126.17M60.44%33.35M150.40%40.31M80.59%29.31M
Operating profit -118.79%-125.13M-88.71%-315.47M-92.60%-94.21M-68.53%-83.93M-114.61%-80.14M-83.83%-57.19M-63.87%-167.17M-80.98%-48.91M-128.91%-49.8M-69.97%-37.34M
Net non-operating interest income expense -11.38%4.53M29.49%16.95M-24.60%3.61M33.66%3.78M39.29%4.45M124.30%5.11M212.14%13.09M430.09%4.79M132.51%2.83M140.91%3.19M
Non-operating interest income -7.98%6.36M18.18%24.48M-17.20%5.52M20.48%5.74M23.82%6.32M64.98%6.91M159.61%20.71M239.95%6.66M120.62%4.76M127.96%5.1M
Non-operating interest expense 1.73%1.82M-1.25%7.53M1.76%1.9M1.24%1.96M-1.99%1.87M-5.98%1.79M101.43%7.63M77.18%1.87M105.30%1.94M109.19%1.91M
Other net income (expense) -211.92%-432K-156.28%-1.09M-172.06%-503K-139.83%-137K-288.71%-836K-14.03%386K5.74%1.94M48.51%698K-21.28%344K-8.28%443K
Gain on sale of security ------------------------------------75.00%-7K
Other non- operating income (expenses) -211.92%-432K-156.28%-1.09M-172.06%-503K-139.83%-137K-288.71%-836K-14.03%386K5.74%1.94M48.51%698K-21.28%344K-13.31%443K
Income before tax -134.13%-121.03M-96.92%-299.61M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.42M-131.95%-46.63M-67.19%-33.71M
Income tax 0.00%1K0.00%1K
Net income -134.13%-121.03M-96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M
Net income continuous Operations -134.13%-121.03M-96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M
Minority interest income
Net income attributable to the parent company -134.13%-121.03M-96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -134.13%-121.03M-96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M
Basic earnings per share -108.64%-1.69-69.45%-4.66-93.06%-1.39-48.24%-1.26-93.55%-1.2-44.64%-0.81-22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.62
Diluted earnings per share -108.64%-1.69-69.45%-4.66-93.06%-1.39-48.24%-1.26-93.55%-1.2-44.64%-0.81-22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More